XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Allocation of Share-based Compensation
Total stock-based compensation expense related to all of the Company’s stock-based awards was recorded in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2025202420252024
Research and development1,982 2,010 $6,020 $5,577 
Selling, general and administrative2,414 3,498 8,073 8,824 
Total stock-based compensation expense$4,396 $5,508 $14,093 $14,401 
Schedule of Stock Option Activity
Activity for stock options is shown below:
Number of OptionsWeighted Average Exercise Price per ShareWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands $)
Outstanding at December 31, 202419,177,571 $3.39 7.6$7,317 
Granted6,512,400 3.16 
Exercised(864,563)2.26 1,738
Canceled/Forfeited(2,293,910)3.05 
Expired(626,082)7.33 
Outstanding at September 30, 202521,905,416 3.29 7.7$9,804 
Exercisable at September 30, 202510,105,606 $3.41 6.6$6,621 
Schedule of Determination of Fair Value
The estimated grant-date fair value of all the Company’s stock options was calculated using the Black-Scholes option pricing model, based on the following assumptions:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2025202420252024
Expected term (in years)
5.8-6.1
6.0-6.1
5.5-6.1
5.5-6.1
Volatility
91%-91%
82%-84%
90%-92%
81%-84%
Risk-free interest rate
3.8%-4.0%
3.7%-4.4%
3.8%-4.4%
3.7%-4.6%
Dividend Yield—%—%—%—%
Schedule of Non-vested Share Activity
Activity for restricted stock units is shown below:
Number of SharesWeighted Average Grant Date Fair Value
Unvested as of December 31, 20243,711,710 $3.12 
Granted1,667,362 3.19 
Vested(469,008)3.93 
Forfeitures(489,704)2.56 
Unvested as of September 30, 20254,420,360 $3.12